Kurve Therapeutics
Early Stage
Bypassing the Blood-Brain Barrier
Analytics
Platform
Rialto Markets
Start Date
08/03/2022
Close Date
08/03/2023
Min. Goal
$580
Max. Goal
$50,000,000
Min. Investment
$580
Security Type
Equity - Common
Funding Type
RegA+
Price Per Share
$5.80
Location
Lynnwood, Washington
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Kurve Therapeutics is raising funds through Reg A+ crowdfunding with Rialto Markets as the Broker-Dealer. The company has developed its patented Controlled Particle Dispersion (CPD) intranasal drug delivery technology. The technology creates a focused flow through the curved pathways of the nasal cavity and allows access to the olfactory region to treat neurogenerative diseases. Kurve Therapeutics’ technology has been featured in multiple publications and has completed Phase II studies on Alzheimer’s patients. Marc Giroux, Tom McDowell, and Glenn Cornett founded Kurve Therapeutics in 2019. The current crowdfunding campaign has a maximum target of $50,000,000. The campaign proceeds will be used for asset purchase, marketing, clinical studies, contract manufacturing, and working capital.
Balance Sheet
|
Cash and Cash Equivalents |
$373,804 |
|
Accounts and Notes Receivable |
$15,000 |
| Total Assets |
$640,574 |
|
Accounts Payable & Accrued Liabilities |
$28,331 |
|
Long Term Debt |
$507,500 |
|
Total Liabilities |
$606,726 |
|
Total Stockholders' Equity |
$33,848 |
| Total Liabilities and Equity |
$640,574 |
Statement of Comprehensive Income Information
|
Total Revenues |
$70,700 |
|
Costs & Expenses Applicable to Rev |
$128,344 |
| Net Income |
$-65,427 |
|
Earnings Per Share - Basic |
$0.00 |
|
Earnings Per Share - Diluted |
$0.00 |
Auditor: Assurance Dimensions
Financials as of: 08/03/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Analyst Report 
Pending Review